Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Biomimetic Peptide Concentration 1 + 5 percent Minoxidil: To evaluate efficacy of Biomimetic Peptide Concentration 1 + 5 percent Minoxidil
Total duration of the study 5 Months
Interven
Sponsors
Dr Debraj Shome
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of pattern hair loss. 2. Hamilton-Norwood grade II, III (males), Ludwig s grades I (females). 3. Presence of an obvious visible thinning area suitable for target-area assessment. 4. Willingness to avoid starting any new hair-growth treatment during the study period. 5. Ability to comply with scheduled visits, photography, and daily application instructions
Exclusion criteria
Exclusion criteria: 1. Scarring alopecia 2. Alopecia areata or other non-pattern hair loss 3. Active scalp disease (infection, psoriasis, dermatitis) 4. Prior hair transplant in target area 5. Recent treatments: Minoxidil within 4 weeks; Finasteride/Dutasteride within 3 months; PRP/exosomes/microneedling within 3 months 6. Pregnancy / lactation 7. Uncontrolled systemic illness 8. Known hypersensitivity 9. Participation in another clinical study within 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the change in hair fall from baseline to Week 12 using the Hair Pull Test, measured by the number of hairs extracted per pull from the same scalp region using a standardized technique.Timepoint: Baseline, Week 4, Week 8, and Week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess improvement in scalp hair appearance from baseline to Week 12 using standardized global photographs evaluated by blinded independent assessors on a 7 point Global Photographic Assessment scale.Timepoint: Baseline, Week 4, Week 8, and Week 12;To assess participant perceived reduction in hair fall using a Subject Self Assessment Questionnaire scored on a 5 point scale ranging from much worse to much improved.Timepoint: Week 4, Week 8, and Week 12;To assess participant perceived improvement in hair density using a Subject Self Assessment Questionnaire scored on a 5 point scale ranging from much worse to much improved.Timepoint: Week 4, Week 8, and Week 12;To assess participant perceived improvement in hair thickness using a Subject Self Assessment Questionnaire scored on a 5 point scale ranging from much worse to much improved.Timepoint: Week 4, Week 8, and Week 12;To document visible changes in the target scalp area using standardized photography at predefined study visits.Timepoint: Baseline, Week 4, Week 8, and Week 12;To evaluate safety and tolerability by recording local scalp reactions including erythema, dryness, scaling, burning or stinging, itching, and any other adverse events.Timepoint: Baseline, Week 4, Week 8, and Week 12 | — |
Countries
India
Contacts
Public ContactMs Kartiki Wani
The Esthetic Clinics (TEC )
Outcome results
None listed